• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 16, 1998

View Archived Issues

Inspire enters into strategic partnership with Kissei

Read More

Pylorid-containing triple therapy effective in eradicating H. pylori

Read More

Matrix completes enrollment in IntraDose trials

Read More

Corixa's MUC-1 vaccine technology receives patent protection

Read More

Wafer formulation of rizatriptan delivers fast and effective migraine relief

Read More

Positive clinical data from temozolomide trials presented at European oncology meeting

Read More

Integrin antagonists discovered as part of Lilly/Cor Therapeutics collaboration

Read More

Anthraquinone telomerase inhibitors developed at CRC Technology

Read More

Lilly discovers inhibitors of PSA enzymatic activity for cancer, BPH

Read More

Arylsulfonamides as inhibitors of PLA2, cytokine release and neurodegeneration

Read More

Potent and selective 5-HT1B/1D antagonists designed by Merck KGaA

Read More

Organon designs novel acylguanidine-containing thrombin inhibitors

Read More

Joint venture for development of MPS I treatment now a reality

Read More

Design and synthesis of cycloheptylurea factor Xa inhibitors reported by DuPont

Read More

S-23751: new 5-HT1A/5-HT7 receptor ligand with anxiolytic activity

Read More

SKB selects V-ATPase inhibitor SB-242784 for further evaluation

Read More

Merck KGaA discovers potent dual 5-HT1A antagonist and 5-HT reuptake inhibitor

Read More

Algos releases phase III clinical trial results for MorphiDex

Read More

Committee recommends approval of test to identify candidates for treatment with Herceptin

Read More

European-wide approval for Viagra

Read More

RPR will introduce CombiPatch in U.S. during third quarter

Read More

Novel treatment for breast cancer available for licensing

Read More

BioCryst licenses small-molecule neuraminidase inhibitors to J&J companies

Read More

FDA clears diagnostic for DVT - a potentially life-threatening disorder

Read More

YM-75466 exerts antithrombotic effects at doses that do not alter bleeding and coagulation times

Read More

European marketing application for Myotrophin withdrawn

Read More

Bioniche receives EU registration for Cystistat

Read More

Biovail subsidiary will market clot buster in Canada

Read More

Cytogen's Cellcor subsidiary closes operations this week

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 3, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 3, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 1, 2025
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • Robert Paris, vice president, Moderna

    Moderna expands mRNA tech to latent viruses, cancer, rare disease

    BioWorld
    Post pandemic, Moderna Inc. is broadening the applications of mRNA technology to cancer, rare diseases, latent viruses and respiratory viruses, “taking advantage”...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe